The death domain kinase RIP mediates the TNF-induced NF-kappaB signal
- PMID: 9529147
- DOI: 10.1016/s1074-7613(00)80535-x
The death domain kinase RIP mediates the TNF-induced NF-kappaB signal
Abstract
The death domain serine/threonine kinase RIP interacts with the death receptors Fas and tumor necrosis receptor 1 (TNFR1). In vitro, RIP stimulates apoptosis, SAPK/JNK, and NF-kappaB activation. To define the physiologic role(s) that RIP plays in regulating apoptosis in vivo, we introduced a rip null mutation in mice through homologous recombination. RIP-deficient mice appear normal at birth but fail to thrive, displaying extensive apoptosis in both the lymphoid and adipose tissue and dying at 1-3 days of age. In contrast to a normal thymic anti-Fas response, rip-/- cells are highly sensitive to TNFalpha-induced cell death. Sensitivity to TNFalpha-mediated cell death in rip-/- cells is accompanied by a failure to activate the transcription factor NF-kappaB.
Similar articles
-
The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase.Mol Cell Biol. 2000 Sep;20(18):6638-45. doi: 10.1128/MCB.20.18.6638-6645.2000. Mol Cell Biol. 2000. PMID: 10958661 Free PMC article.
-
The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation.Mol Cell Biol. 1999 Aug;19(8):5759-67. doi: 10.1128/MCB.19.8.5759. Mol Cell Biol. 1999. PMID: 10409763 Free PMC article.
-
TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex.Immunity. 1996 Apr;4(4):387-96. doi: 10.1016/s1074-7613(00)80252-6. Immunity. 1996. PMID: 8612133
-
Modulation of life and death by the TNF receptor superfamily.Oncogene. 1998 Dec 24;17(25):3261-70. doi: 10.1038/sj.onc.1202568. Oncogene. 1998. PMID: 9916988 Review.
-
HIV and apoptosis: a complex interaction between cell death and virus survival.Prog Mol Subcell Biol. 2004;36:117-49. doi: 10.1007/978-3-540-74264-7_7. Prog Mol Subcell Biol. 2004. PMID: 15171610 Review. No abstract available.
Cited by
-
Association of RIPK1 and RIPK2 Gene Polymorphisms with Rheumatoid Arthritis in a Chinese Han Population.Appl Clin Genet. 2024 Oct 19;17:159-169. doi: 10.2147/TACG.S472418. eCollection 2024. Appl Clin Genet. 2024. PMID: 39444708 Free PMC article.
-
Effects of oral iron chelator deferasirox on human malignant lymphoma cells.Korean J Hematol. 2012 Sep;47(3):194-201. doi: 10.5045/kjh.2012.47.3.194. Epub 2012 Sep 25. Korean J Hematol. 2012. PMID: 23071474 Free PMC article.
-
Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models.Cell Death Dis. 2012 Nov 29;3(11):e437. doi: 10.1038/cddis.2012.176. Cell Death Dis. 2012. PMID: 23190609 Free PMC article.
-
RIP1 potentiates BPDE-induced transformation in human bronchial epithelial cells through catalase-mediated suppression of excessive reactive oxygen species.Carcinogenesis. 2013 Sep;34(9):2119-28. doi: 10.1093/carcin/bgt143. Epub 2013 Apr 30. Carcinogenesis. 2013. PMID: 23633517 Free PMC article.
-
NFκB and ubiquitination: partners in disarming RIPK1-mediated cell death.Immunol Res. 2012 Dec;54(1-3):214-26. doi: 10.1007/s12026-012-8321-7. Immunol Res. 2012. PMID: 22477525 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous